CXCL3 binds to CXCR2, a receptor on breast cancer cells, and activates FAK, which promotes a mesenchymal phenotype, invasion, and metastasis of breast cancer cells (41) F12 expression might affect the OS of PTC patients by regulating metabolic pathways (42). This evidence concerns the gene CXCL3 and breast cancer.